Cohort study analyzes abandonment factors of new buprenorphine prescriptions for opioid use disorder in US adults, indicating challenges in treatment adherence.
This cohort study analyzes factors associated with abandonment of newly prescribed buprenorphine among US adults from 2020 to 2024.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: